Scotiabank analyst Andres Coello downgrades Telefonica Brasil (NYSE:VIV) from Sector Outperform to Sector Perform and raises the price target from $9.9 to $11.5.
Expert Ratings for Albireo Pharma
Analysts have provided the following ratings for Albireo Pharma (NASDAQ:ALBO) within the last quarter: Bullish Somewhat Bullish Indifferent…